Collagen and related extracellular matrix proteins in atherosclerotic plaque development

Current Opinion in Lipidology

Volumn 25, Issue 5, 2014, Pages 394-399

  Shami, Annelie ^a   Gonçalves, Isabel ^b,c   Hultgardh Nilsson, Anna ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Atherosclerotic plaque; Collagen; Extracellular matrix; Lipid retention; Small leucine rich repeat proteins

Indexed keywords

COLLAGEN; DECORIN; FIBROMODULIN; PROTEIN DERIVATIVE; SCLEROPROTEIN; SMALL LEUCINE RICH REPEAT PROTEIN; UNCLASSIFIED DRUG;

ATHEROSCLEROTIC PLAQUE; CALCIFICATION; CELL FUNCTION; CELL INTERACTION; EXTRACELLULAR MATRIX; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; REVIEW; SMOOTH MUSCLE FIBER; ATHEROSCLEROSIS; CHEMISTRY; GENETICS; HUMAN; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY; STROKE;

ATHEROSCLEROSIS; COLLAGEN; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; HUMANS; MYOCARDIAL INFARCTION; PLAQUE, ATHEROSCLEROTIC; STROKE;

EID: 84921438183     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0000000000000112     Document Type: Review

References (55)

1. Laslett LJ, Alagona P Jr, Clark BA 3rd, et al. The worldwide environment of cardiovascular disease: Prevalence, diagnosis, therapy, and policy issues: A report from the American College of Cardiology. J Am Coll Cardiol 2012; 60: S1-S49.
2. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics- 2012 update: A report from the American Heart Association. Circulation 2012; 125: E2-e220.
3. Adiguzel E, Ahmad PJ, Franco C, Bendeck MP. Collagens in the progression and complications of atherosclerosis. Vasc Med 2009; 14: 73-89.
4. Fogelstrand P, Boren J. Retention of atherogenic lipoproteins in the artery wall and its role in atherogenesis. Nutr Metab Cardiovasc Dis 2012; 22: 1-7.
5. Legein B, Temmerman L, Biessen EA, Lutgens E. Inflammation and immune system interactions in atherosclerosis. Cell Mol Life Sci 2013; 70: 3847-3869.
6. Murata K, Motayama T, Kotake C. Collagen types in various layers of the human aorta and their changes with the atherosclerotic process. Atherosclerosis 1986; 60: 251-262.
7. Katsuda S, Okada Y, Minamoto T, et al. Collagens in human atherosclerosis. Immunohistochemical analysis using collagen type-specific antibodies. Arterioscler Thromb 1992; 12: 494-502.
8. Smith EB. The influence of age and atherosclerosis on the chemistry of aortic intima.2. Collagen and mucopolysaccharides. J Atheroscler Res 1965; 5: 241-248.
9. Shchelkunova TA, Morozov IA, Rubtsov PM, et al. Changes in levels of gene expression in human aortal intima during atherogenesis. Biochemistry (Mosc) 2013; 78: 463-470.
10. Chait A, Wight TN. Interaction of native and modified low-density lipoproteins with extracellular matrix. Curr Opin Lipidol 2000; 11: 457-463.
11. Khalil MF, Wagner WD, Goldberg IJ. Molecular interactions leading to lipoprotein retention and the initiation of atherosclerosis. Arterioscler Thromb Vasc Biol 2004; 24: 2211-2218.
12. Witos J, Saint-Guirons J,Meinander K, et al. Collagen I and III and their decorin modified surfaces studied by atomic force microscopy and the elucidation of their affinity toward positive apolipoprotein B-100 residue by quartz crystal microbalance. Analyst 2011; 136: 3777-3782.
13. Frontini MJ, O'Neil C, Sawyez C, et al. Lipid incorporation inhibits Srcdependent assembly of fibronectin and type I collagen by vascular smooth muscle cells. Circ Res 2009; 104: 832-841.
14. Wang WL, Yeh YT, Chen LJ, Chiu JJ. Regulation of fibrillar collagen-mediated smooth muscle cell proliferation in response to chemical stimuli by telomere reverse transcriptase through c-Myc. Biomaterials 2014; 35: 3829-3839.
15. Chen CN, Li YS, Yeh YT, et al. Synergistic roles of platelet-derived growth factor-BB and interleukin-1beta in phenotypic modulation of human aortic smooth muscle cells. Proc Natl Acad Sci U S A 2006; 103: 2665-2670.
16. Yeh YT, Lee CI, Lim SH, et al. Convergence of physical and chemical signaling in the modulation of vascular smooth muscle cell cycle and proliferation by fibrillar collagen-regulated P66Shc. Biomaterials 2012; 33: 6728-6738.
17. Orr AW, Lee MY, Lemmon JA, et al. Molecular mechanisms of collagen isotype-specific modulation of smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 2009; 29: 225-231.
18. Kong CH, Lin XY, Woo CC, et al. Characteristics of aortic wall extracellular matrix in patients with acute myocardial infarction: Tissue microarray detection of collagen I, collagen III and elastin levels. Interact Cardiovasc Thorac Surg 2013; 16: 11-15.
19. Yasuda O, Zhang SH, Miyamoto Y, Maeda N. Differential expression of the alpha1 type VIII collagen gene by smooth muscle cells from atherosclerotic plaques of apolipoprotein-E-deficient mice. J Vasc Res 2000; 37: 158-169.
20. Plenz GA, Deng MC, Robenek H, Volker W. Vascular collagens: Spotlight on the role of type VIII collagen in atherogenesis. Atherosclerosis 2003; 166: 1-11.
21. Lopes J, Adiguzel E, Gu S, et al. Type VIII collagen mediates vessel wall remodeling after arterial injury and fibrous cap formation in atherosclerosis. Am J Pathol 2013; 182: 2241-2253.
22. Ovchinnikova OA, Folkersen L, Persson J, et al. The collagen cross-linking enzyme lysyl oxidase is associated with the healing of human atherosclerotic lesions. J Intern Med 2014; doi: 10.1111/joim.12228.
23. Shai SY, Sukhanov S, Higashi Y, et al. Smooth muscle cell-specific insulin-like growth factor-1 overexpression in Apoe-/- mice does not alter atherosclerotic plaque burden but increases features of plaque stability. Arterioscler Thromb Vasc Biol 2010; 30: 1916-1924.
24. Blackstock CD, Higashi Y, Sukhanov S, et al. Insulin-like growth factor-1 increases synthesis of collagen type i via induction of the mRNA-binding protein LARP6 expression and binding to the 5' stem-loop of COL1a1 and COL1a2 mRNA. J Biol Chem 2014; 289: 7264-7274.
25. Danzaki K, Matsui Y, Ikesue M, et al. Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2012; 32: 273-280.
26. Gistera A, Robertson AK, Andersson J, et al. Transforming growth factor-beta signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway. Sci Transl Med 2013; 5: 196ra100: P. 1-9.
27. Cheng C, Tempel D, van Haperen R, et al. Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation 2006; 113: 2744-2753.
28. Koskinas KC, Sukhova GK, Baker AB, et al. Thin-capped atheromata with reduced collagen content in pigs develop in coronary arterial regions exposed to persistently low endothelial shear stress. Arterioscler Thromb Vasc Biol 2013; 33: 1494-1504.
29. Phinikaridou A, Hua N, Pham T, Hamilton JA. Regions of low endothelial shear stress colocalize with positive vascular remodeling and atherosclerotic plaque disruption: An in vivo magnetic resonance imaging study. Circ Cardiovasc Imaging 2013; 6: 302-310.
30. Hastings NE, Simmers MB, McDonald OG, et al. Atherosclerosis-prone hemodynamics differentially regulates endothelial and smooth muscle cell phenotypes and promotes pro-inflammatory priming. Am J Physiol Cell Physiol 2007; 293: C1824-1833.
31. Qi YX, Qu MJ, Long DK, et al. Rho-GDP dissociation inhibitor alpha downregulated by low shear stress promotes vascular smooth muscle cell migration and apoptosis: A proteomic analysis. Cardiovasc Res 2008; 80: 114-122.
32. Stone PH, Saito S, Takahashi S, et al. Prediction of progression of coronary artery disease and clinical outcomes using vascular profiling of endothelial shear stress and arterial plaque characteristics: The PREDICTION Study. Circulation 2012; 126: 172-181.
33. Kato S, Endo I, Fujimura M, et al. Serum carboxy-terminal telopeptide of type I collagen (ICTP) as a surrogate marker for vulnerable plaques in atherosclerotic patients: A pilot study. Atherosclerosis 2013; 229: 182-185.
34. Heinegard D. Proteoglycans and more-from molecules to biology. Int J Exp Pathol 2009; 90: 575-586.
35. Frey H, Schroeder N, Manon-Jensen T, et al. Biological interplay between proteoglycans and their innate immune receptors in inflammation. FEBS J 2013; 280: 2165-2179.
36. Hocking AM, Shinomura T, McQuillan DJ. Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol 1998; 17: 1-19.
37. Fischer JW, Steitz SA, Johnson PY, et al. Decorin promotes aortic smooth muscle cell calcification and colocalizes to calcified regions in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2004; 24: 2391-2396.
38. Yan J, Stringer SE, Hamilton A, et al. Decorin GAG synthesis and TGF-beta signaling mediate Ox-LDL-induced mineralization of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2011; 31: 608-615.
39. Singla S, Hu C, Mizeracki A, Mehta JL. Decorin in atherosclerosis. Ther Adv Cardiovasc Dis 2011; 5: 305-314.
40. Scott RA, Paderi JE, Sturek M, Panitch A. Decorin mimic inhibits vascular smooth muscle proliferation and migration. PLoS One 2013; 8: E82456.
41. Afroze T, Yang G, Khoshbin A, et al. Calcium efflux activity of plasma membrane Ca2+ ATPase-4 (PMCA4) mediates cell cycle progression in vascular smooth muscle cells. J Biol Chem 2014; 289: 7221-7231.
42. Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 1995; 15: 551-561.
43. Neufeld EB, Zadrozny LM, Phillips D, et al. Decorin and biglycan retain LDL in disease-prone valvular and aortic subendothelial intimal matrix. Atherosclerosis 2014; 233: 113-121.
44. Melchior JT, Sawyer JK, Kelley KL, et al. LDL particle core enrichment in cholesteryl oleate increases proteoglycan binding and promotes atherosclerosis. J Lipid Res 2013; 54: 2495-2503.
45. Tang T, Wilson PG, Thompson JC, et al. Prevention of TGFbeta induction attenuates angII-stimulated vascular biglycan and atherosclerosis in Ldlr-/- mice. J Lipid Res 2013; 54: 2255-2264.
46. Oberkersch R, Maccari F, Bravo AI, et al. Atheroprotective remodelling of vascular dermatan sulphate proteoglycans in response to hypercholesterolaemia in a rat model. Int J Exp Pathol 2014; 95: 181-190.
47. Brito V, Mellal K, Portelance SG, et al. Induction of antianti-idiotype antibodies against sulfated glycosaminoglycans reduces atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2012; 32: 2847-2854.
48. Reese SP, Underwood CJ, Weiss JA. Effects of decorin proteoglycan on fibrillogenesis, ultrastructure, and mechanics of type I collagen gels. Matrix Biol 2013; 32: 414-423.
49. Marzoll A, Melchior-Becker A, Cipollone F, Fischer JW. Small leucine-rich proteoglycans in atherosclerotic lesions: Novel targets of chronic statin treatment? J Cell Mol Med 2011; 15: 232-243.
50. Oldberg A, Antonsson P, Lindblom K, Heinegard D. A collagen-binding 59-kd protein (fibromodulin) is structurally related to the small interstitial proteoglycans PG-S1 and PG-S2 (decorin). EMBO J 1989; 8: 2601-2604.
51. Shami A, Gustafsson R, Kalamajski S, et al. Fibromodulin deficiency reduces low-density lipoprotein accumulation in atherosclerotic plaques in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 2013; 33: 354-361.
52. Ezura Y, Chakravarti S, Oldberg A, et al. Differential expression of lumican and fibromodulin regulate collagen fibrillogenesis in developing mouse tendons. J Cell Biol 2000; 151: 779-788.
53. Halasz K, Kassner A, Morgelin M, Heinegard D. COMP acts as a catalyst in collagen fibrillogenesis. J Biol Chem 2007; 282: 31166-31173.
54. Wang L, Zheng J, Du Y, et al. Cartilage oligomeric matrix protein maintains the contractile phenotype of vascular smooth muscle cells by interacting with alpha(7)beta(1) integrin. Circ Res 2010; 106: 514-525.
55. Wang L, Zheng J, Bai X, et al. ADAMTS-7 mediates vascular smooth muscle cell migration and neointima formation in balloon-injured rat arteries. Circ Res 2009; 104: 688-698.